Searched query = "Budd-Chiari syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|09/04/2020||13/06/2019||Treatment of thrombosis in the abdominal veins||Treatment of portal, mesenteric, and splenic vein thrombosis with rivaroxaban. A pilot, prospective cohort study - RIVASVT100||Splanchnic vein thrombosis (SVT) is an unusual site manifestation of venous thromboembolism (VTE). It includes the Budd-Chiari syndrome (BCS), portal vein thrombosis (PVT), mesenteric vein thrombosis (MVT) and splenic vein thrombosis (spVT). PVT is the most frequent manifestation of SVT, followed by MVT. ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]||Trade Name: rivaroxaban 20 mg|
Product Name: rivaroxaban
|University of Insubria||NULL||Authorised-recruitment may be ongoing or finished||Female: yes|
|2||ChiCTR1800017925||2018-08-31||2018-08-22||D-printed bidirectional angiography versus traditional angiography for the diagnosis and effect of Budd–Chiari Syndrome With Inferior Vena Cava Obstruction:-----A Prospective Single blind Randomized Trial||D-printed bidirectional angiography versus traditional angiography for the diagnosis and effect of Budd–Chiari Syndrome With Inferior Vena Cava Obstruction:-----A Prospective Single blind Randomized Trial||Budd-Chiari syndrome||Gold Standard:traditional angiography;Index test:3D-printed bidirectional angiography;||Affiliated Hospital of Xuzhou Medical University||NULL||Pending||19||68||Both||Target condition:60;Difficult condition:0||NULL|
|3||JPRN-UMIN000015319||2012/06/01||12/10/2014||The efficacy of dabigatran for portal vein thrombosis/Budd-Chiari syndrome||Portal vein thrombosis or Budd-Chiari syndrome||dabigatran||Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology||NULL||Recruiting||20years-old||70years-old||Male and Female||20||Not selected||Japan|